LH
Labcorp·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 4
Bearish signal 2
Consensus Rating "Buy"
Ample Liquidity
High Cash/net Profit Ratio
Low Cash Short-term Debt Ratio
Revenue Beats Expectation
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About LH
Labcorp Holdings Inc.
A leading global life sciences company that provides clinical testing services for healthcare industry
Healthcare Providers and Services
--
04/24/1991
New York Stock Exchange
70,000
12-31
Common stock
358 South Main Street, Burlington, North Carolina, 27215
--
Labcorp Holdings Inc., a Delaware corporation, was founded in 1971. The Company is a leading global life sciences company that is deeply integrated in guiding patient care. The Company provides comprehensive clinical laboratory and end-to-end drug development services through its LabCorp Diagnostics (LCD) and Covance Drug Development (CDD) divisions. LabCorp is positioned at the fusion of research and care delivery for more precise and personalized healthcare, combining world-class diagnostic and drug development capabilities.
Earnings Call
Q1/2025
Estimate EPS3.73
Actual EPS3.84
Estimate Revenue3.40B
Actual Revenue3.35B
Diagnostics Dilemma: Contradictions in Revenue Growth and Invitae's Integration Impact
May 13,2025 11:09
Earnings Decrypt
Earnings Decrypt
Q2/2025
Estimate EPS4.16
Actual EPS4.35
Estimate Revenue3.49B
Actual Revenue3.53B
LabCorp's Q2 2025 Earnings Call: Unpacking Contradictions in Diagnostics Growth and Strategy
Jul 24,2025 07:51
Earnings Decrypt
Earnings Decrypt
Q3/2025
Estimate EPS4.14
Actual EPS4.18
Estimate Revenue3.56B
Actual Revenue3.56B
Labcorp's Q3 2025 Earnings Call: Contradictions in PAMA Impact, Invitae Integration, and Strategic Priorities
Oct 28,2025 12:45
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
LH has released its 2025 Q3 earnings. EPS was reported at 4.18, versus the expected 4.14, beating expectations. The chart below visualizes how LH has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
LH has released its 2025 Q3 earnings report, with revenue of 3.56B, reflecting a YoY change of 8.58%, and net profit of 261.50M, showing a YoY change of 54.19%. The Sankey diagram below clearly presents LH's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
